生理性心脏肥大的模糊逻辑。 - Suppr

Suppr

超能文献

The fuzzy logic of physiological cardiac hypertrophy.

作者信息

Dorn Gerald W

机构信息

Center for Molecular Cardiovascular Research, University of Cincinnati, Ohio 45267-0839, USA.

出版信息

Hypertension. 2007 May;49(5):962-70. doi: 10.1161/HYPERTENSIONAHA.106.079426. Epub 2007 Mar 26.

DOI:10.1161/HYPERTENSIONAHA.106.079426

PMID:17389260

Abstract

摘要

相似文献

The fuzzy logic of physiological cardiac hypertrophy.

Hypertension. 2007 May;49(5):962-70. doi: 10.1161/HYPERTENSIONAHA.106.079426. Epub 2007 Mar 26.

Apoptosis signal-regulating kinase 1/p38 signaling pathway negatively regulates physiological hypertrophy.

Circulation. 2008 Jan 29;117(4):545-52. doi: 10.1161/CIRCULATIONAHA.107.710434. Epub 2008 Jan 14.

The biochemical response of the heart to hypertension and exercise.

Trends Biochem Sci. 2004 Nov;29(11):609-17. doi: 10.1016/j.tibs.2004.09.002.

MicroRNAs in cardiac hypertrophy: angels or devils.

Wiley Interdiscip Rev RNA. 2011 Jan-Feb;2(1):124-34. doi: 10.1002/wrna.61. Epub 2010 Nov 22.

The therapeutic potential of miRNAs regulated in settings of physiological cardiac hypertrophy.

Future Med Chem. 2014 Feb;6(2):205-22. doi: 10.4155/fmc.13.196.

[Computer fuzzy control of physiological workload intensity of human body during sports training].

Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 1997 Dec;14(4):367-72.

Is treating cardiac hypertrophy salutary or detrimental: the two faces of Janus.

Am J Physiol Heart Circ Physiol. 2003 Apr;284(4):H1043-7. doi: 10.1152/ajpheart.00990.2002.

Cardiac remodeling: UPS lost in transit.

Circ Res. 2005 Nov 11;97(10):964-6. doi: 10.1161/01.RES.0000193563.53859.3e.

Modulating cardiac hypertrophy by manipulating myocardial lipid metabolism?

Circulation. 2002 Mar 12;105(10):1152-4.

The alpha1-adrenergic receptors in cardiac hypertrophy: signaling mechanisms and functional implications.

Cell Signal. 2015 Oct;27(10):1984-93. doi: 10.1016/j.cellsig.2015.06.009. Epub 2015 Jul 10.

引用本文的文献

Engineering Nanoparticles and Bioscaffolds for Targeted microRNA Delivery in Cardiovascular Regeneration-A Comprehensive Review.

FASEB J. 2025 Jul 31;39(14):e70871. doi: 10.1096/fj.202501226RR.

Distinct morphometric features of cardiomyocytes isolated from mouse hypertrophy models: An ImageJ analysis combined with machine learning algorithms.

Physiol Rep. 2025 Jun;13(12):e70425. doi: 10.14814/phy2.70425.

ATF6β is not essential for the development of physiological cardiac hypertrophy.

PLoS One. 2025 Apr 7;20(4):e0320178. doi: 10.1371/journal.pone.0320178. eCollection 2025.

SNX3 mediates heart failure by interacting with HMGB1 and subsequently facilitating its nuclear-cytoplasmic translocation.

Acta Pharmacol Sin. 2025 Apr;46(4):964-975. doi: 10.1038/s41401-024-01436-z. Epub 2025 Jan 3.

FGFR4 Is Required for Concentric Growth of Cardiac Myocytes during Physiologic Cardiac Hypertrophy.

J Cardiovasc Dev Dis. 2024 Oct 12;11(10):320. doi: 10.3390/jcdd11100320.

Chronic cold exposure causes left ventricular hypertrophy that appears to be physiological.

J Exp Biol. 2024 Oct 15;227(20). doi: 10.1242/jeb.247476. Epub 2024 Oct 17.

Cardiomyopathy discovered during pregnancy: Insights from speckle tracking echocardiography in a cohort of pregnant patients.

ARYA Atheroscler. 2024 Mar-Apr;20(2):8-16. doi: 10.48305/arya.2024.42400.2932.

Cardiomyocyte-specific overexpression of FPN1 diminishes cardiac hypertrophy induced by chronic intermittent hypoxia.

J Cell Mol Med. 2024 Jul;28(14):e18543. doi: 10.1111/jcmm.18543.

A Mitochondrial Basis for Heart Failure Progression.

Cardiovasc Drugs Ther. 2024 Dec;38(6):1161-1171. doi: 10.1007/s10557-024-07582-0. Epub 2024 Jun 15.

SIRT1 regulates mitochondrial fission to alleviate high altitude hypoxia inducedcardiac dysfunction in rats via the PGC-1α-DRP1/FIS1/MFF pathway.

Apoptosis. 2024 Oct;29(9-10):1663-1678. doi: 10.1007/s10495-024-01954-5. Epub 2024 Apr 27.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

The fuzzy logic of physiological cardiac hypertrophy.

作者信息

Dorn Gerald W

机构信息

Center for Molecular Cardiovascular Research, University of Cincinnati, Ohio 45267-0839, USA.

出版信息

Hypertension. 2007 May;49(5):962-70. doi: 10.1161/HYPERTENSIONAHA.106.079426. Epub 2007 Mar 26.

DOI:10.1161/HYPERTENSIONAHA.106.079426

PMID:17389260

Abstract

摘要

相似文献

The fuzzy logic of physiological cardiac hypertrophy.

Hypertension. 2007 May;49(5):962-70. doi: 10.1161/HYPERTENSIONAHA.106.079426. Epub 2007 Mar 26.

Apoptosis signal-regulating kinase 1/p38 signaling pathway negatively regulates physiological hypertrophy.

Circulation. 2008 Jan 29;117(4):545-52. doi: 10.1161/CIRCULATIONAHA.107.710434. Epub 2008 Jan 14.

The biochemical response of the heart to hypertension and exercise.

Trends Biochem Sci. 2004 Nov;29(11):609-17. doi: 10.1016/j.tibs.2004.09.002.

MicroRNAs in cardiac hypertrophy: angels or devils.

Wiley Interdiscip Rev RNA. 2011 Jan-Feb;2(1):124-34. doi: 10.1002/wrna.61. Epub 2010 Nov 22.

The therapeutic potential of miRNAs regulated in settings of physiological cardiac hypertrophy.

Future Med Chem. 2014 Feb;6(2):205-22. doi: 10.4155/fmc.13.196.

[Computer fuzzy control of physiological workload intensity of human body during sports training].

Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 1997 Dec;14(4):367-72.

Is treating cardiac hypertrophy salutary or detrimental: the two faces of Janus.

Am J Physiol Heart Circ Physiol. 2003 Apr;284(4):H1043-7. doi: 10.1152/ajpheart.00990.2002.

Cardiac remodeling: UPS lost in transit.

Circ Res. 2005 Nov 11;97(10):964-6. doi: 10.1161/01.RES.0000193563.53859.3e.

Modulating cardiac hypertrophy by manipulating myocardial lipid metabolism?

Circulation. 2002 Mar 12;105(10):1152-4.

The alpha1-adrenergic receptors in cardiac hypertrophy: signaling mechanisms and functional implications.

Cell Signal. 2015 Oct;27(10):1984-93. doi: 10.1016/j.cellsig.2015.06.009. Epub 2015 Jul 10.

引用本文的文献

Engineering Nanoparticles and Bioscaffolds for Targeted microRNA Delivery in Cardiovascular Regeneration-A Comprehensive Review.

FASEB J. 2025 Jul 31;39(14):e70871. doi: 10.1096/fj.202501226RR.

Distinct morphometric features of cardiomyocytes isolated from mouse hypertrophy models: An ImageJ analysis combined with machine learning algorithms.

Physiol Rep. 2025 Jun;13(12):e70425. doi: 10.14814/phy2.70425.

ATF6β is not essential for the development of physiological cardiac hypertrophy.

PLoS One. 2025 Apr 7;20(4):e0320178. doi: 10.1371/journal.pone.0320178. eCollection 2025.

SNX3 mediates heart failure by interacting with HMGB1 and subsequently facilitating its nuclear-cytoplasmic translocation.

Acta Pharmacol Sin. 2025 Apr;46(4):964-975. doi: 10.1038/s41401-024-01436-z. Epub 2025 Jan 3.

FGFR4 Is Required for Concentric Growth of Cardiac Myocytes during Physiologic Cardiac Hypertrophy.

J Cardiovasc Dev Dis. 2024 Oct 12;11(10):320. doi: 10.3390/jcdd11100320.

Chronic cold exposure causes left ventricular hypertrophy that appears to be physiological.

J Exp Biol. 2024 Oct 15;227(20). doi: 10.1242/jeb.247476. Epub 2024 Oct 17.

Cardiomyopathy discovered during pregnancy: Insights from speckle tracking echocardiography in a cohort of pregnant patients.

ARYA Atheroscler. 2024 Mar-Apr;20(2):8-16. doi: 10.48305/arya.2024.42400.2932.

Cardiomyocyte-specific overexpression of FPN1 diminishes cardiac hypertrophy induced by chronic intermittent hypoxia.

J Cell Mol Med. 2024 Jul;28(14):e18543. doi: 10.1111/jcmm.18543.

A Mitochondrial Basis for Heart Failure Progression.

Cardiovasc Drugs Ther. 2024 Dec;38(6):1161-1171. doi: 10.1007/s10557-024-07582-0. Epub 2024 Jun 15.

SIRT1 regulates mitochondrial fission to alleviate high altitude hypoxia inducedcardiac dysfunction in rats via the PGC-1α-DRP1/FIS1/MFF pathway.

Apoptosis. 2024 Oct;29(9-10):1663-1678. doi: 10.1007/s10495-024-01954-5. Epub 2024 Apr 27.